Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroscience
Biotech
GSK pens $2.5B pact for ABL's blood-brain barrier-bypassing tech
GSK has continued to flesh out its neuroscience strategy with a $2.5 billion deal to use a South Korean biotech to bypass the blood-brain barrier.
James Waldron
Apr 7, 2025 7:00am
Clario continues acquisition spree with imaging firm NeuroRx
Mar 18, 2025 6:50am
Biohaven's biopolar med fails pivotal test
Mar 3, 2025 5:14pm
Newleos unveils with $93M and 4 ex-Roche programs
Feb 13, 2025 12:00am
Tenvie takes off with $200M, assets and exec from Denali
Jan 8, 2025 8:00am
Misconduct and the future of neurodegenerative disease research
Nov 15, 2024 9:06am
